[go: up one dir, main page]

JPH05301821A - Medicated cosmetic - Google Patents

Medicated cosmetic

Info

Publication number
JPH05301821A
JPH05301821A JP4103404A JP10340492A JPH05301821A JP H05301821 A JPH05301821 A JP H05301821A JP 4103404 A JP4103404 A JP 4103404A JP 10340492 A JP10340492 A JP 10340492A JP H05301821 A JPH05301821 A JP H05301821A
Authority
JP
Japan
Prior art keywords
acid
cosmeceutical
present
effect
organic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4103404A
Other languages
Japanese (ja)
Inventor
Hiroyuki Hasegawa
宏幸 長谷川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP4103404A priority Critical patent/JPH05301821A/en
Publication of JPH05301821A publication Critical patent/JPH05301821A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

(57)【要約】 【目的】 皮膚又は頭皮に対する刺激が少なく、かゆ
み、フケに対する充分な防止効果を発揮し、且つその効
果の持続性に優れた薬用化粧料の提供。 【構成】 本発明の薬用化粧料は、有機酸及び有機酸塩
による緩衝液中に、抗菌効果を有する生薬抽出成分を含
有する。
(57) [Summary] [Purpose] To provide a cosmeceutical product which is less irritating to the skin or scalp, exhibits a sufficient effect of preventing itching and dandruff, and has excellent sustainability of the effect. [Structure] The cosmeceutical composition of the present invention contains a crude drug extract component having an antibacterial effect in a buffer solution containing an organic acid and an organic acid salt.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、薬用化粧料、詳しく
は、皮膚及び頭皮に適用して、主としてかゆみ、フケの
発生を防止する薬用化粧料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmeceutical composition, and more particularly to a cosmeceutical composition which is applied to the skin and scalp to prevent the occurrence of itching and dandruff.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】皮膚又
は頭皮のかゆみ及びフケ等は、皮膚又は頭皮に存在する
細菌等により皮脂等が分解されて分解物及び代謝物がで
きたり、該分解物及び代謝物に皮膚又は頭皮が刺激され
たりすること等に起因するものである。そこで、抗菌効
果を有する適当な薬剤等によって、上記細菌の増殖を防
ぎ、上記細菌による皮脂の分解物及び代謝物を少なく
し、皮膚又は頭皮のかゆみ、フケ等を防ぐことが試みら
れており、抗菌効果を有するフケ防止剤としては、植物
の精油もしくは溶媒抽出物を含有してなるものが知られ
ている(特開昭59−88412号公報等参照)。
BACKGROUND OF THE INVENTION Itching, dandruff, etc. of the skin or scalp is caused by bacteria or the like present in the skin or scalp to decompose sebum or the like to give a decomposed product or a metabolite. And the irritation of the skin or scalp by metabolites. Therefore, it has been attempted to prevent the growth of the above-mentioned bacteria by a suitable drug having an antibacterial effect, reduce the decomposition products and metabolites of sebum by the above-mentioned bacteria, and prevent itching of the skin or scalp, dandruff, etc. As an anti-dandruff agent having an antibacterial effect, one containing an essential oil of a plant or a solvent extract is known (see JP-A-59-88412, etc.).

【0003】しかしながら、上記のフケ防止剤は、抗菌
効果を有するものの、その効果は不充分なものであり、
しかもその効果の持続性に欠けるものであった。また、
通常の抗菌剤は、上述のような皮膚又は頭皮のかゆみ、
フケ等の防止の目的で多量に用いると、皮膚又は頭皮へ
の刺激が強く、実用性に欠けるものであった。
However, although the above anti-dandruff agent has an antibacterial effect, its effect is insufficient.
Moreover, the effect was lacking in sustainability. Also,
Ordinary antibacterial agents include itching of the skin or scalp as described above,
When used in a large amount for the purpose of preventing dandruff and the like, the skin or scalp was strongly irritated and was not practical.

【0004】従って、本発明の目的は、皮膚又は頭皮に
対する刺激が少なく、かゆみ、フケに対する充分な防止
効果を発揮し、且つその効果の持続性に優れた薬用化粧
料を提供することにある。
Therefore, it is an object of the present invention to provide a cosmeceutical which has less irritation to the skin or scalp, exhibits a sufficient effect of preventing itching and dandruff, and is excellent in the sustainability of the effect.

【0005】[0005]

【課題を解決するための手段】本発明者等は、有機酸及
び有機酸塩による緩衝液に、抗菌効果を有する生薬抽出
成分を組み合わせた薬用化粧料が、上記目的を達成する
ものであることを知見し本発明に到達した。即ち、本発
明は、有機酸及び有機酸塩による緩衝液中に、抗菌効果
を有する生薬抽出成分を含有する薬用化粧料を提供する
ものである。
Means for Solving the Problems The present inventors have found that a cosmeceutical composition in which a crude drug extract component having an antibacterial effect is combined with a buffer solution of an organic acid and an organic acid salt achieves the above object. That is, the present invention has been reached. That is, the present invention provides a cosmeceutical containing a crude drug extract having an antibacterial effect in a buffer solution containing an organic acid and an organic acid salt.

【0006】以下、本発明の薬用化粧料について詳述す
る。本発明の薬用化粧料に含有される有機酸としては、
例えば、ギ酸、酢酸、プロピオン酸、酪酸、吉草酸等の
直鎖脂肪酸;シュウ酸、マロン酸、コハク酸、グルタル
酸、アジピン酸、ピメリン酸、フマル酸、マレイン酸、
フタル酸、イソフタル酸、テレフタル酸等のジカルボン
酸;グルタミン酸、アスパラギン酸等の酸性アミノ酸;
グリコール酸、乳酸、ヒドロキシアクリル酸、α−オキ
シ酪酸、グリセリン酸、タルトロン酸、リンゴ酸、酒石
酸、クエン酸、サリチル酸(o,m,p)、没食子酸、
マンデル酸、トロパ酸、アスコルビン酸、グルコン酸等
のオキシ酸;桂皮酸、安息香酸、フェニル酢酸、ニコチ
ン酸、カイニン酸、ソルビン酸、ピロリドンカルボン
酸、トリメリット酸、ベンゼンスルホン酸、トルエンス
ルホン酸等が挙げられる。また、本発明の薬用化粧料に
含有される有機酸塩としては、上記有機酸の塩が挙げら
れ、酢酸、クエン酸、乳酸、及びそれらのアルカリ金属
塩等が好ましく、乳酸又は乳酸ナトリウム、及びこれら
の組み合わせが特に好ましい。
The cosmeceutical composition of the present invention will be described in detail below. The organic acid contained in the cosmeceutical of the present invention,
For example, straight chain fatty acids such as formic acid, acetic acid, propionic acid, butyric acid, valeric acid; oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, fumaric acid, maleic acid,
Dicarboxylic acids such as phthalic acid, isophthalic acid and terephthalic acid; acidic amino acids such as glutamic acid and aspartic acid;
Glycolic acid, lactic acid, hydroxyacrylic acid, α-oxybutyric acid, glyceric acid, tartronic acid, malic acid, tartaric acid, citric acid, salicylic acid (o, m, p), gallic acid,
Oxyacids such as mandelic acid, tropic acid, ascorbic acid, gluconic acid; cinnamic acid, benzoic acid, phenylacetic acid, nicotinic acid, kainic acid, sorbic acid, pyrrolidonecarboxylic acid, trimellitic acid, benzenesulfonic acid, toluenesulfonic acid, etc. Is mentioned. The organic acid salt contained in the cosmeceutical of the present invention includes salts of the above organic acids, preferably acetic acid, citric acid, lactic acid, and alkali metal salts thereof, and the like, lactic acid or sodium lactate, and These combinations are particularly preferable.

【0007】上記有機酸及び有機酸塩は、本発明の薬用
化粧料において、主に、抗菌効果、保湿効果、緩衝作用
等の機能を発揮するもので、その含有量(上記有機酸及
び有機酸塩の合計の含有量)は、本発明の薬用化粧料の
全組成中に、好ましくは0.01〜25.0重量%であ
り、更に好ましくは0.10〜10.0重量%である。
本発明の薬用化粧料の液性は、含有される生薬抽出成
分、使用目的等により異なるが、通常、pH3〜7、特
にpH4〜6の範囲とすることが好ましい。上記緩衝液
の緩衝能としては、pH4.0〜6.0において20〜
200mMであることが好ましい。
The above-mentioned organic acid and organic acid salt mainly exhibit functions such as an antibacterial effect, a moisturizing effect and a buffering effect in the cosmeceutical of the present invention, and the content thereof (the above-mentioned organic acid and organic acid). The total content of salts) is preferably 0.01 to 25.0% by weight, and more preferably 0.10 to 10.0% by weight in the total composition of the cosmeceutical of the present invention.
The liquidity of the cosmeceutical of the present invention varies depending on the galenical extract component contained, the purpose of use and the like, but it is usually preferably in the range of pH 3 to 7, particularly pH 4 to 6. The buffer capacity of the above-mentioned buffer solution is 20 to 20 at pH 4.0 to 6.0.
It is preferably 200 mM.

【0008】本発明の薬用化粧料に含有される生薬抽出
成分の原料となる生薬としては、その抽出成分が抗菌効
果を有するものであれば、特に制限されないが、オウゴ
ン、オウバク、緑茶、ケイヒ、チョウジ、ニクズク、ウ
ワウルシ、アロエ、生姜、イチョウ、ザクロ実、紅花、
ハッカ、シソ、オウセイ、エンメイソウ、キンギンカ、
クジン、ゲンノショウ、サンショウ、ジュウヤク、ビ
ワ、ビャクシ、モモ、コキノシタ、レンギョウ、シラカ
ンハ、ホップ、ラベンダー、レモン、ムクロジ等が好ま
しいものとして挙げられ、特にチョウジ、緑茶及びムク
ロジが好ましい。
The crude drug which is a raw material for the crude drug extract component contained in the cosmeceutical of the present invention is not particularly limited as long as the extract component has an antibacterial effect, but it is not limited thereto. Cloves, nutmeg, oak, aloe, ginger, ginkgo, pomegranate, safflower,
Mint, perilla, pearl oyster, neat grass, goldfish,
Preferred examples thereof include kujin, gennosho, salamander, sycamore, loquat, juniper, peach, kokinoshita, forsythia, shirakanha, hops, lavender, lemon, sucrose, and the like, and clove, green tea and sucrose are particularly preferable.

【0009】上記生薬抽出成分は、常法により上記生薬
から抽出されたもので、抽出法には制限されず、例え
ば、チョウジ抽出液であれば、次の(チョウジ抽出液の
抽出)にしめすような抽出法により得られる。(チョウ
ジ抽出液の抽出)日本薬局方チョウジを乾燥し、細切し
たもの10Kgに、50V/V % エタノール(化粧品原料
基準、無水エタノール及び同精製水にて調製)を加えて
24時間浸漬し、圧搾分離して抽出液を得る。
The above-mentioned crude drug extract component is extracted from the above crude drug by a conventional method and is not limited to the extraction method. For example, in the case of a clove extract, the following (extraction of clove extract) is shown. It can be obtained by various extraction methods. (Extraction of clove extract) Japanese Pharmacopoeia Clove was dried and finely chopped into 10 kg, and 50 V / V% ethanol (a cosmetic raw material standard, prepared with absolute ethanol and purified water) was added and immersed for 24 hours, Extraction is obtained by pressing and separating.

【0010】本発明の薬用化粧料において、上記生薬抽
出成分は、上記有機酸及び有機酸塩の存在下に、かゆ
み、フケの起因となる細菌の増殖を抑制するもので、そ
の含有量は、本発明の薬用化粧料の全組成中に、好まし
くは0.001〜25.0重量%であり、更に好ましく
は0.005〜5.0重量%である。
In the cosmeceutical composition of the present invention, the crude drug extract component suppresses the growth of bacteria causing itching and dandruff in the presence of the organic acid and the organic acid salt, and the content thereof is: The content of the cosmeceutical composition of the present invention is preferably 0.001 to 25.0% by weight, and more preferably 0.005 to 5.0% by weight.

【0011】本発明の薬用化粧料は、通常、上記必須成
分を水及びエタノール等の水性溶媒に含有させて用いら
れる。上記水性溶媒としては、低級アルコールが好まし
く、低級アルコールの含有量は、本発明の薬用化粧料中
に、30〜80重量%、さらに好ましくは40〜60重
量%である。本発明の薬用化粧料には、上記必須成分の
他に、通常の化粧料に含有される成分、例えば、油性基
剤、エモリエント剤、ゲル化剤、各種乳化剤、香料、パ
ラヒドロキシ安息香酸エステル等の防腐剤、ブチルヒド
ロキシアニソール等の酸化防止剤、染料等の着色剤、プ
ロピレングリコール等の湿潤剤、皮膜剤、増粘剤、血行
促進剤、ビタミン類等を適宜配合することができる。
The cosmeceutical of the present invention is usually used by containing the above essential components in water and an aqueous solvent such as ethanol. The above-mentioned aqueous solvent is preferably a lower alcohol, and the content of the lower alcohol in the cosmeceutical of the present invention is 30 to 80% by weight, more preferably 40 to 60% by weight. In the cosmeceutical composition of the present invention, in addition to the above essential components, components contained in ordinary cosmetics, for example, oily bases, emollients, gelling agents, various emulsifiers, fragrances, parahydroxybenzoic acid esters, etc. Antiseptics, antioxidants such as butylhydroxyanisole, coloring agents such as dyes, wetting agents such as propylene glycol, film agents, thickeners, blood circulation promoters, vitamins and the like can be appropriately added.

【0012】本発明の薬用化粧料は、通常の化粧料と同
様にして製造することができ、例えば、化粧水、乳液、
ヘアーローション、ヘアートニック、ヘアーリキッド、
シャンプー、リンス、養毛・育毛剤等として使用され、
必要に応じ加圧炭酸ガス等の噴射剤と共に容器に充填し
て使用される。
The cosmeceutical of the present invention can be produced in the same manner as ordinary cosmetics. For example, lotion, emulsion,
Hair lotion, hair tonic, hair liquid,
Used as shampoo, conditioner, hair restorer, hair restorer, etc.,
It is used by filling it into a container together with a propellant such as pressurized carbon dioxide gas as necessary.

【0013】[0013]

【実施例】以下、本発明の薬用化粧料の実施例を挙げ、
本発明を具体的に説明する。
EXAMPLES Examples of the cosmeceutical of the present invention will be given below.
The present invention will be specifically described.

【0014】(実施例1)下記処方による本発明の薬用
化粧料を調製した。 (成分) (重量%) ・エタノール 60 ・乳酸/乳酸ナトリウム 4.5/1.6 ・チョウジエキス 0.1 ・香料 0.3 ・流動パラフィン 2.0 ・ポリオキシエチレン(20)セチルエーテル 0.5 ・精製水 Balance
Example 1 A cosmeceutical of the present invention having the following formulation was prepared. (Component) (wt%)-Ethanol 60-Lactic acid / sodium lactate 4.5 / 1.6-Clove extract 0.1-Fragrance 0.3-Liquid paraffin 2.0-Polyoxyethylene (20) cetyl ether 0.1. 5 ・ Purified water Balance

【0015】(実施例2)下記処方による本発明の薬用
化粧料(ミスド状ヘアローション)を調製した。 (成分) (重量%) ・エタノール 40 ・クエン酸/クエン酸ナトリウム 2.5/1.0 ・オウゴンエキス 2.0 ・ポリオキシエチレン硬化ヒマシ油 0.1 ・香料 0.1 ・精製水 Balance 上記原液70%にLPG/DME(50/50)30%
を添加し、耐圧容器に密封した。
Example 2 A cosmeceutical (misted hair lotion) of the present invention having the following formulation was prepared. (Component) (wt%)-Ethanol 40-Citric acid / sodium citrate 2.5 / 1.0-Ougon extract 2.0-Polyoxyethylene hydrogenated castor oil 0.1-Fragrance 0.1-Purified water Balance Above Stock solution 70% LPG / DME (50/50) 30%
Was added and the container was sealed in a pressure container.

【0016】(比較例1)下記処方による薬用化粧料を
調製した。 (成分) (重量%) ・エタノール 60 ・チョウジエキス 0.01 ・香料 0.3 ・流動パラフィン 2.0 ・ポリオキシエチレン(20)セチルエーテル 0.5 ・精製水 Balance (比較例2)下記処方による本発明の薬用化粧料を調製
した。 (成分) (重量%) ・エタノール 60 ・乳酸/乳酸ナトリウム 4.5/1.6 ・香料 0.3 ・流動パラフィン 2.0 ・ポリオキシエチレン(20)セチルエーテル 0.5 ・精製水 Balance
Comparative Example 1 A cosmeceutical composition having the following formulation was prepared. (Component) (wt%)-Ethanol 60-Clove extract 0.01-Fragrance 0.3-Liquid paraffin 2.0-Polyoxyethylene (20) cetyl ether 0.5-Purified water Balance (Comparative Example 2) The following formulation To prepare the cosmeceutical of the present invention. (Component) (wt%)-Ethanol 60-Lactic acid / sodium lactate 4.5 / 1.6-Fragrance 0.3-Liquid paraffin 2.0-Polyoxyethylene (20) cetyl ether 0.5-Purified water Balance

【0017】(試験例1)上記実施例及び比較例で調製
した薬用化粧料について、それぞれ、下記〔測定法〕に
より頭皮上の好気性菌数を測定するとともに、ハーフヘ
ッドによるかゆみ防止効果を、下記〔判定基準〕による
パネラーの判定の平均値(パネラー数n=5)によって
判定した。それらの結果を下記〔表1〕及び〔表2〕に
示した。 〔測定法〕調製した薬用化粧料を所定量、頭皮に直接塗
布した。頭皮塗布後所定の時間ごとに生理食塩水を用い
て、内径2cm2 のガラス製カップを用いて抽出した。
得られた抽出液をSCD培地にて、37℃で48時間培
養して菌数を測定した。
(Test Example 1) With respect to the cosmeceutical preparations prepared in the above Examples and Comparative Examples, the number of aerobic bacteria on the scalp was measured by the following [Measurement Method], and the itching prevention effect by the half head was measured. The average value (number of panelists n = 5) of the panelists' determination according to the following [criteria] was used for the determination. The results are shown in [Table 1] and [Table 2] below. [Measurement method] A prescribed amount of the prepared medicated cosmetic was directly applied to the scalp. After application to the scalp, physiological saline was used at predetermined intervals and extraction was performed using a glass cup having an inner diameter of 2 cm 2 .
The obtained extract was cultured in SCD medium at 37 ° C. for 48 hours, and the number of bacteria was measured.

【0018】[0018]

【表1】 [Table 1]

【0019】[0019]

【表2】 [Table 2]

【0020】[0020]

【発明の効果】本発明の薬用化粧料は、皮膚又は頭皮に
対する刺激が少なく、かゆみ、フケに対する充分な防止
効果を発揮し、且つその効果の持続性に優れたものであ
る。
EFFECT OF THE INVENTION The cosmeceutical of the present invention has little irritation to the skin or scalp, exhibits a sufficient effect of preventing itching and dandruff, and is excellent in the sustainability of the effect.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 有機酸及び有機酸塩による緩衝液中に、
抗菌効果を有する生薬抽出成分を含有する薬用化粧料。
1. In a buffer solution containing an organic acid and an organic acid salt,
A cosmeceutical containing a crude drug extract having an antibacterial effect.
JP4103404A 1992-04-23 1992-04-23 Medicated cosmetic Pending JPH05301821A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4103404A JPH05301821A (en) 1992-04-23 1992-04-23 Medicated cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4103404A JPH05301821A (en) 1992-04-23 1992-04-23 Medicated cosmetic

Publications (1)

Publication Number Publication Date
JPH05301821A true JPH05301821A (en) 1993-11-16

Family

ID=14353119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4103404A Pending JPH05301821A (en) 1992-04-23 1992-04-23 Medicated cosmetic

Country Status (1)

Country Link
JP (1) JPH05301821A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018540A1 (en) * 1994-01-10 1995-07-13 The Procter & Gamble Company Tea extract and process for preparing
EP0644752A4 (en) * 1992-06-16 1997-04-23 Marvin Klein Composition for the treatment of skin.
JPH09255519A (en) * 1996-03-19 1997-09-30 Noevir Co Ltd Antibacterial low irritating cosmetic material
US5674477A (en) * 1995-02-28 1997-10-07 Ahluwalia; Gurpreet S. Reduction of hair growth
JPH1017440A (en) * 1996-07-02 1998-01-20 Hoyu Co Ltd Hair growing and restoring agent
JPH1045562A (en) * 1996-08-08 1998-02-17 Noevir Co Ltd Antimicrobial and low-irritant cosmetic
JPH1081615A (en) * 1996-08-16 1998-03-31 Kao Corp Composition for treating hair and scalp
JP2001172124A (en) * 1999-12-16 2001-06-26 Kao Corp Aerosol cosmetics
KR100441059B1 (en) * 2001-10-19 2004-07-21 주식회사 태평양 Composition for improving conditions of scalp and hair
EP1457780A4 (en) * 2001-12-27 2006-05-17 Shiseido Co Ltd Drugs for ameliorating itch, rough skin or hypersensitive skin or for whitening via inhibition of the production and release of stem cell factor
JPWO2004091640A1 (en) * 2003-04-11 2006-07-06 株式会社鳳凰堂 Skin protection composition

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54145226A (en) * 1978-04-28 1979-11-13 Maanaa Kosumechitsukusu Kk Cosmetics
JPS5677215A (en) * 1979-11-28 1981-06-25 Pola Chem Ind Inc Cosmetic for skin
JPS5916813A (en) * 1982-07-16 1984-01-28 Lion Corp cosmetics
JPS6127910A (en) * 1984-07-19 1986-02-07 Kao Corp Cosmetic
JPS61109708A (en) * 1984-10-31 1986-05-28 Kobayashi Kooc:Kk Cosmetic
JPS61194030A (en) * 1985-02-25 1986-08-28 Shiseido Co Ltd Cosmetic
JPS6267028A (en) * 1985-09-18 1987-03-26 Shiseido Co Ltd Skin external preparation
JPS63215612A (en) * 1987-03-03 1988-09-08 Pola Chem Ind Inc Sebum secretion inhibitor
JPS6483008A (en) * 1987-09-25 1989-03-28 Sansho Seiyaku Kk Drug for external use
JPH01199916A (en) * 1988-02-04 1989-08-11 Sansho Seiyaku Co Ltd Drug for external use
JPH0248512A (en) * 1988-08-08 1990-02-19 Kobayashi Kose Co Ltd Hair tonic
JPH03236322A (en) * 1990-02-13 1991-10-22 Kobayashi Kose Co Ltd Skin drug for external use
JPH04346911A (en) * 1991-05-24 1992-12-02 Nonogawa Shoji Kk Cosmetic
JPH0578231A (en) * 1991-09-19 1993-03-30 Nonogawa Shoji Kk Cosmetic
JPH05139950A (en) * 1991-11-26 1993-06-08 Pola Chem Ind Inc Cosmetic

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54145226A (en) * 1978-04-28 1979-11-13 Maanaa Kosumechitsukusu Kk Cosmetics
JPS5677215A (en) * 1979-11-28 1981-06-25 Pola Chem Ind Inc Cosmetic for skin
JPS5916813A (en) * 1982-07-16 1984-01-28 Lion Corp cosmetics
JPS6127910A (en) * 1984-07-19 1986-02-07 Kao Corp Cosmetic
JPS61109708A (en) * 1984-10-31 1986-05-28 Kobayashi Kooc:Kk Cosmetic
JPS61194030A (en) * 1985-02-25 1986-08-28 Shiseido Co Ltd Cosmetic
JPS6267028A (en) * 1985-09-18 1987-03-26 Shiseido Co Ltd Skin external preparation
JPS63215612A (en) * 1987-03-03 1988-09-08 Pola Chem Ind Inc Sebum secretion inhibitor
JPS6483008A (en) * 1987-09-25 1989-03-28 Sansho Seiyaku Kk Drug for external use
JPH01199916A (en) * 1988-02-04 1989-08-11 Sansho Seiyaku Co Ltd Drug for external use
JPH0248512A (en) * 1988-08-08 1990-02-19 Kobayashi Kose Co Ltd Hair tonic
JPH03236322A (en) * 1990-02-13 1991-10-22 Kobayashi Kose Co Ltd Skin drug for external use
JPH04346911A (en) * 1991-05-24 1992-12-02 Nonogawa Shoji Kk Cosmetic
JPH0578231A (en) * 1991-09-19 1993-03-30 Nonogawa Shoji Kk Cosmetic
JPH05139950A (en) * 1991-11-26 1993-06-08 Pola Chem Ind Inc Cosmetic

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0644752A4 (en) * 1992-06-16 1997-04-23 Marvin Klein Composition for the treatment of skin.
WO1995018540A1 (en) * 1994-01-10 1995-07-13 The Procter & Gamble Company Tea extract and process for preparing
US5674477A (en) * 1995-02-28 1997-10-07 Ahluwalia; Gurpreet S. Reduction of hair growth
US5776442A (en) * 1995-02-28 1998-07-07 Ahluwalia; Gurpreet S. Reduction of hair growth
JPH09255519A (en) * 1996-03-19 1997-09-30 Noevir Co Ltd Antibacterial low irritating cosmetic material
JPH1017440A (en) * 1996-07-02 1998-01-20 Hoyu Co Ltd Hair growing and restoring agent
JPH1045562A (en) * 1996-08-08 1998-02-17 Noevir Co Ltd Antimicrobial and low-irritant cosmetic
JPH1081615A (en) * 1996-08-16 1998-03-31 Kao Corp Composition for treating hair and scalp
JP2001172124A (en) * 1999-12-16 2001-06-26 Kao Corp Aerosol cosmetics
KR100441059B1 (en) * 2001-10-19 2004-07-21 주식회사 태평양 Composition for improving conditions of scalp and hair
EP1457780A4 (en) * 2001-12-27 2006-05-17 Shiseido Co Ltd Drugs for ameliorating itch, rough skin or hypersensitive skin or for whitening via inhibition of the production and release of stem cell factor
JPWO2004091640A1 (en) * 2003-04-11 2006-07-06 株式会社鳳凰堂 Skin protection composition

Similar Documents

Publication Publication Date Title
JPH05301821A (en) Medicated cosmetic
JP2009539950A (en) Topical beauty composition containing wasabi
JP3027302B2 (en) Hair restoration / hair restoration
JP2003286153A (en) Skin care composition
JP3055882B2 (en) Skin cosmetics
JPH05271046A (en) Dermal medicine for external use
JP7519753B2 (en) Compositions containing D-chiro-inositol
JP2780803B2 (en) External preparation for skin
JPH11302147A (en) Cosmetic
JP2000212057A (en) Cosmetic composition
JPH0240042B2 (en)
JPWO1995019160A1 (en) Blood flow improver and cosmetic
JPH08119828A (en) Cosmetic
WO2018012157A1 (en) Melanin production inhibitor, skin-lightening agent, fibroblast cell activator, collagen and/or elastin production promotor, and wrinkle-improving agent
EP1040757B1 (en) Antiseptic/antifungal agent and endermic liniment composition which contains it
JP7203522B2 (en) Compositions containing D-chiro-inositol
JP4222973B2 (en) Elastase activity inhibitors and cosmetics
JPH09309814A (en) Preparation for external use for skin
JP2002114660A (en) Malodor generation suppressing composition
JPH11279023A (en) Composition for external use
JP4065647B2 (en) Transparent aqueous base
JPH0632710A (en) Skin external preparation
JP4233732B2 (en) Cosmetics
JPH08188517A (en) Sebum secretion inhibitor
JP2811479B2 (en) Hair restoration